Search research articles
Contact Us
Filters
Showing results (501-510 of 547) with videos related to
Page
of 55
Sort By:
BMC Cardiovascular Disorders
|
May 23, 2018
Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): rationale and design of a randomized clinical trial
Elisabetta Tonet, Elisa Maietti, Giorgio Chiaranda, et al.
European Journal of Internal Medicine
|
April 26, 2021
Serum uric acid and outcomes in patients with chronic heart failure through the whole spectrum of ejection fraction phenotypes: Analysis of the ESC-EORP Heart Failure Long-Term (HF LT) Registry
Giuseppe Ambrosio, Marisa G Crespo Leiro, Lars H Lund, et al.
Cancer Research
|
September 20, 2023
Combinatorial Treatment with PARP and MAPK Inhibitors Overcomes Phenotype Switch-Driven Drug Resistance in Advanced Melanoma
Lorenza P Ferretti, Flurina Böhi, Deena M Leslie Pedrioli, et al.
European Journal of Heart Failure
|
April 8, 2017
Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry
Ovidiu Chioncel, Mitja Lainscak, Petar M Seferovic, et al.
European Journal of Heart Failure
|
June 15, 2022
Biomarkers for the prediction of heart failure and cardiovascular events in patients with type 2 diabetes: a position statement from the Heart Failure Association of the European Society of Cardiology
Peter Seferović, Dimitrios Farmakis, Antoni Bayes-Genis, et al.
Platelets
|
December 3, 2020
Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure
Gianluca Campo, Marco Contoli, Alberto Fogagnolo, et al.
American Heart Journal
|
June 23, 2007
Two-by-two factorial comparison of high-bolus-dose tirofiban followed by standard infusion versus abciximab and sirolimus-eluting versus bare-metal stent implantation in patients with acute myocardial infarction: design and rationale for the MULTI-STRATEGY trial
Marco Valgimigli, Leonardo Bolognese, Maurizio Anselmi, et al.
European Journal of Preventive Cardiology
|
January 18, 2018
The chronic ischaemic cardiovascular disease ESC Pilot Registry: Results of the six-month follow-up
Michel Komajda, Mathieu Kerneis, Luigi Tavazzi, et al.
European Heart Journal
|
June 12, 2010
Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease
Jasper Jan Brugts, Aaron Isaacs, Eric Boersma, et al.
Cell
|
August 7, 2012
Scl represses cardiomyogenesis in prospective hemogenic endothelium and endocardium
Ben Van Handel, Amélie Montel-Hagen, Rajkumar Sasidharan, et al.
Page
of 55
Search research articles
Search
Showing results (501-510 of 547) with videos related to
Sort By:
Page
of 55
BMC Cardiovascular Disorders
|
May 23, 2018
Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): rationale and design of a randomized clinical trial
Elisabetta Tonet, Elisa Maietti, Giorgio Chiaranda, et al.
European Journal of Internal Medicine
|
April 26, 2021
Serum uric acid and outcomes in patients with chronic heart failure through the whole spectrum of ejection fraction phenotypes: Analysis of the ESC-EORP Heart Failure Long-Term (HF LT) Registry
Giuseppe Ambrosio, Marisa G Crespo Leiro, Lars H Lund, et al.
Cancer Research
|
September 20, 2023
Combinatorial Treatment with PARP and MAPK Inhibitors Overcomes Phenotype Switch-Driven Drug Resistance in Advanced Melanoma
Lorenza P Ferretti, Flurina Böhi, Deena M Leslie Pedrioli, et al.
European Journal of Heart Failure
|
April 8, 2017
Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry
Ovidiu Chioncel, Mitja Lainscak, Petar M Seferovic, et al.
European Journal of Heart Failure
|
June 15, 2022
Biomarkers for the prediction of heart failure and cardiovascular events in patients with type 2 diabetes: a position statement from the Heart Failure Association of the European Society of Cardiology
Peter Seferović, Dimitrios Farmakis, Antoni Bayes-Genis, et al.
Platelets
|
December 3, 2020
Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure
Gianluca Campo, Marco Contoli, Alberto Fogagnolo, et al.
American Heart Journal
|
June 23, 2007
Two-by-two factorial comparison of high-bolus-dose tirofiban followed by standard infusion versus abciximab and sirolimus-eluting versus bare-metal stent implantation in patients with acute myocardial infarction: design and rationale for the MULTI-STRATEGY trial
Marco Valgimigli, Leonardo Bolognese, Maurizio Anselmi, et al.
European Journal of Preventive Cardiology
|
January 18, 2018
The chronic ischaemic cardiovascular disease ESC Pilot Registry: Results of the six-month follow-up
Michel Komajda, Mathieu Kerneis, Luigi Tavazzi, et al.
European Heart Journal
|
June 12, 2010
Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease
Jasper Jan Brugts, Aaron Isaacs, Eric Boersma, et al.
Cell
|
August 7, 2012
Scl represses cardiomyogenesis in prospective hemogenic endothelium and endocardium
Ben Van Handel, Amélie Montel-Hagen, Rajkumar Sasidharan, et al.
Page
of 55